Current treatment for lobular carcinoma in situ
β Scribed by Frank E. Gump; David Kinne; Gordon F. Schwartz
- Book ID
- 105531071
- Publisher
- Springer
- Year
- 1998
- Tongue
- English
- Weight
- 380 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1068-9265
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Lobular carcinoma in situ (LCIS) is not only a relative newcomer among breast lesions, but in its short span of 50 years it has gradually evolved from a rare form of breast cancer to being merely a marker of increased risk. This change has not been without controversy which persists to the present d
## Abstract ## BACKGROUND Lobular carcinoma in situ (LCIS) of the breast is considered a marker for an increased risk of carcinoma in both breasts. However, the frequent association of LCIS with invasive lobular carcinoma (ILC) suggests a precursorβproduct relation. The possible genomic relation b